Tzu-Lin Yeh1,2, Hsin-Yin Hsu2,3, Ming-Chieh Tsai2,4,5, Le-Yin Hsu2, Lee-Ching Hwang3,5, Kuo-Liong Chien2,6. 1. Department of Family Medicine, Hsinchu MacKay Memorial Hospital, Hsinchu, Taiwan. 2. Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan. 3. Department of Family Medicine, Taipei MacKay Memorial Hospital, Taipei, Taiwan. 4. Division of Endocrinology, Department of Internal Medicine, MacKay Memorial Hospital, Tamsui Branch, New Taipei City, Taiwan. 5. Department of Medical Research, MacKay Memorial Hospital, New Taipei City, Taiwan. 6. Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Abstract
OBJECTIVES: To investigate the relationship between metabolically healthy obesity and cardiovascular disease risk in Taiwanese individuals. METHODS: Taiwanese individuals were recruited from a nationwide, representative community-based prospective cohort study and classified according to body mass index as follows: normal weight (18.5-23.9 kilogram (kg)/meter(m)2) and obesity/overweight (≥24 kg/m2). Participants without diabetes, hypertension, and hyperlipidemia and who did not meet the metabolic syndrome without waist circumference criteria were considered metabolically healthy. The study end points were cardiovascular disease morbidity and mortality. Multivariable adjusted hazard ratios and 95% confidence intervals were obtained from a Cox regression analysis. RESULTS: Among 5 358 subjects (mean [standard deviation] age, 44.5 [15.3] years; women, 48.2%), 1 479 were metabolically healthy with normal weight and 491 were metabolically healthy with obesity. The prevalence of metabolically healthy obesity/overweight was 8.6% in the Taiwanese general population, which included individuals who were >20 years old, not pregnant, and did not have CVD (n = 5,719). In the median follow-up period of 13.7 years, 439 cardiovascular disease events occurred overall and 24 in the metabolically healthy obesity group. Compared with the reference group, the metabolically healthy obesity group had a significantly higher cardiovascular disease risk (adjusted hazard ratio: 1.74, 95% confidence interval: 1.02, 2.99). CONCLUSIONS: Individuals with metabolically healthy obesity have a higher risk of cardiovascular disease and require aggressive body weight control for cardiovascular disease control.
OBJECTIVES: To investigate the relationship between metabolically healthy obesity and cardiovascular disease risk in Taiwanese individuals. METHODS: Taiwanese individuals were recruited from a nationwide, representative community-based prospective cohort study and classified according to body mass index as follows: normal weight (18.5-23.9 kilogram (kg)/meter(m)2) and obesity/overweight (≥24 kg/m2). Participants without diabetes, hypertension, and hyperlipidemia and who did not meet the metabolic syndrome without waist circumference criteria were considered metabolically healthy. The study end points were cardiovascular disease morbidity and mortality. Multivariable adjusted hazard ratios and 95% confidence intervals were obtained from a Cox regression analysis. RESULTS: Among 5 358 subjects (mean [standard deviation] age, 44.5 [15.3] years; women, 48.2%), 1 479 were metabolically healthy with normal weight and 491 were metabolically healthy with obesity. The prevalence of metabolically healthy obesity/overweight was 8.6% in the Taiwanese general population, which included individuals who were >20 years old, not pregnant, and did not have CVD (n = 5,719). In the median follow-up period of 13.7 years, 439 cardiovascular disease events occurred overall and 24 in the metabolically healthy obesity group. Compared with the reference group, the metabolically healthy obesity group had a significantly higher cardiovascular disease risk (adjusted hazard ratio: 1.74, 95% confidence interval: 1.02, 2.99). CONCLUSIONS: Individuals with metabolically healthy obesity have a higher risk of cardiovascular disease and require aggressive body weight control for cardiovascular disease control.
Authors: Bjørn Mørkedal; Lars J Vatten; Pål R Romundstad; Lars E Laugsand; Imre Janszky Journal: J Am Coll Cardiol Date: 2013-12-15 Impact factor: 24.094
Authors: Klodian Dhana; Chantal M Koolhaas; Elisabeth F C van Rossum; M Arfan Ikram; Albert Hofman; Maryam Kavousi; Oscar H Franco Journal: PLoS One Date: 2016-04-21 Impact factor: 3.240
Authors: Aino Vesikansa; Juha Mehtälä; Katja Mutanen; Annamari Lundqvist; Tiina Laatikainen; Tero Ylisaukko-Oja; Tero Saukkonen; Kirsi H Pietiläinen Journal: Eur J Health Econ Date: 2022-09-05